Prostate Cancer: Etiology, Diagnosis, and Treatment

Area of Science:

• Oncology
• Urology

Background:

• Prostate cancer is a leading cause of cancer-related death in American men.
• Understanding its etiology, diagnosis, and treatment is crucial for patient outcomes.

Purpose of the Study:

• To provide a comprehensive review of prostate cancer, encompassing etiology, diagnosis, and treatment strategies.
• To summarize current knowledge on genetic alterations, signaling pathways, and inflammation in prostate cancer development.
• To discuss established and emerging diagnostic and therapeutic approaches for various stages of prostate cancer.

Main Methods:

• Review of current literature on prostate cancer etiology, focusing on androgen receptor signaling and genetic landscape.
• Discussion of diagnostic methods including Gleason score, prostate-specific antigen (PSA) levels, MRI, and other biomarkers.
• Analysis of treatment options for localized, metastatic, and castration-resistant prostate cancer.

Main Results:

• Key genetic alterations and signaling pathways (e.g., DNA damage response, PI3K, WNT) implicated in prostate cancer initiation and progression are identified.
• Established diagnostic tools like PSA and Gleason score are discussed alongside advanced methods (e.g., 4Kscore, Prostate Health Index).
• Treatment strategies range from active surveillance and surgery to androgen deprivation therapy, chemotherapy (cabazitaxel), and novel inhibitors for advanced disease.

Conclusions:

• Prostate cancer etiology is multifactorial, involving genetic predispositions and signaling pathways.
• Accurate diagnosis relies on a combination of clinical assessment, biomarkers, and imaging techniques.
• Treatment selection depends on cancer stage and progression, with ongoing research into novel therapeutic strategies.